US EditionPublished • loading... • Updated
Biotech Breakthrough: Latus Bio Doubles Down on AI to Revolutionize Gene Therapy
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biotech Breakthrough: Latus Bio Doubles Down on AI to Revolutionize Gene Therapy
PHILADELPHIA, PA — Latus Bio, Inc. unveiled a significant expansion of its artificial intelligence and machine learning program as the company pushes deeper into AI-driven AAV capsid and payload design. The move positions the Philadelphia-based firm to accelerate gene therapy development by pairing advanced computational modeling with one of the most extensive in vivo datasets in the industry. Latus’ strategy centers on training predictive model…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
